PRESS RELEASE:

MLB EXPANDS PARTERSHIP WITH SPECTRUM SOLUTIONS
FOR 2021 MINOR LEAGUE SEASON

Major League Baseball
April 28th, 2021

First Cross-Property Partnership between Minor League Baseball and Major League Baseball Enables Minor League Players, Staff to use Spectrum Saliva Collection Kits for Testing

Major League Baseball has expanded its partnership with Spectrum Solutions, LLC to facilitate a first-in-class COVID-19 testing program throughout the 2021 Minor League season. Under the first cross-property partnership between Minor League Baseball and Major League Baseball, Spectrum is supplying all 120 Minor League teams with its innovative SDNA-1000 saliva collection kits for all player and staff testing. In addition, Spectrum Solutions has named three-time National League Cy Young Award and 2012 Roberto Clemente Award recipient Clayton Kershaw as a brand ambassador. Broadening its impact at key levels throughout baseball, Spectrum Solutions has also consulted with Little League International to provide guidance as Little League continues to evaluate its 2021 tournament season.

Minor League health and safety protocols include laboratory PCR testing of players and staff members multiple times per week.  The non-invasive SDNA-1000 saliva collection device will be a critical component of MiLB’s COVID-19 health monitoring and testing plan, just as it has been since the start of MLB’s 2020 season.  The collection kits are serving as one of the key interlocking safeguards to help maintain the health and safety of MiLB personnel around the country. During the 2020 Major League season, over 200,000 of Spectrum’s SDNA-1000 saliva collection kits were used by MLB players and personnel to help successfully monitor their health and complete a successful season.  This season, over 125,000 tests have already been administered in the Majors.

Jon Coyles, MLB Vice President, Drug, Health and Safety Programs, said: “Major League Baseball is grateful to Spectrum Solutions for their continued partnership in helping us monitor the well-being of the players and staff throughout all levels of our game.  The personnel of Minor League teams will receive the same unwavering commitment to safety that Spectrum’s products have created in the Majors, and we look forward to a responsible resumption of the Minor League season in 2021.”

“It’s a privilege to be baseball’s first dual-property partner as well as bring the Minor Leagues back to the game nationwide. We engineered our revolutionary saliva-based PCR testing kits for early detection accuracy and safety. No trade-offs,” said Bill Phillips, Chief Operations Officer for Spectrum Solutions. “After all, if an individual is showing symptoms, they may have already exposed others to that possible infection. Our highly sensitive formulation detects infections from saliva samples measuring as low as 200 copies/ml compared to lateral flow rapid antigen tests that need a minimum of 10,000-20,000 copies/ml.”

The Spectrum Solutions SDNA-1000 Saliva Collection Device was the first saliva-based solution to receive the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for COVID-19 testing. It supplants the need for the painful nasal swab process with a more accurate and pain-free saliva collection process. This easy-to-use option was engineered to eliminate user collection errors and provides a path for at-home sample self-collection that mitigates downstream exposure risks by delivering in-device viral inactivation. Offering the safest & most robust biomaterial for detecting COVID-19, the Spectrum SDNA saliva collection system provides over 10 days of post-collection stability with no degradation in sample efficacy.

###

Contact:  Michael Teevan, Major League Baseball, PublicRelations@MLB.com, @MLB_PR, MLBPressBox.com; Jeff Lantz, Minor League Baseball, JLantz@MiLB.com; Tim Rush, Springboard5 for Spectrum Solutions, tim.rush@springboard5.com.

PRESS RELEASE:

MLB EXPANDS PARTERSHIP WITH SPECTRUM SOLUTIONS
FOR 2021 MINOR LEAGUE SEASON

Major League Baseball
April 28th, 2021

First Cross-Property Partnership between Minor League Baseball and Major League Baseball Enables Minor League Players, Staff to use Spectrum Saliva Collection Kits for Testing

           Major League Baseball has expanded its partnership with Spectrum Solutions, LLC to facilitate a first-in-class COVID-19 testing program throughout the 2021 Minor League season.  Under the first cross-property partnership between Minor League Baseball and Major League Baseball, Spectrum is supplying all 120 Minor League teams with its innovative SDNA-1000 saliva collection kits for all player and staff testing.  In addition, Spectrum Solutions has named three-time National League Cy Young Award and 2012 Roberto Clemente Award recipient Clayton Kershaw of the defending World Series Champion Los Angeles Dodgers as a brand ambassador.

Minor League health and safety protocols include laboratory PCR testing of players and staff members multiple times per week.  The non-invasive SDNA-1000 saliva collection device will be a critical component of MiLB’s COVID-19 health monitoring and testing plan, just as it has been since the start of MLB’s 2020 season.  The collection kits are serving as one of the key interlocking safeguards to help maintain the health and safety of MiLB personnel around the country. During the 2020 Major League season, over 200,000 of Spectrum’s SDNA-1000 saliva collection kits were used by MLB players and personnel to help successfully monitor their health and complete a successful season.  This season, over 125,000 tests have already been administered in the Majors.

Jon Coyles, MLB Vice President, Drug, Health and Safety Programs, said: “Major League Baseball is grateful to Spectrum Solutions for their continued partnership in helping us monitor the well-being of the players and staff throughout all levels of our game.  The personnel of Minor League teams will receive the same unwavering commitment to safety that Spectrum’s products have created in the Majors, and we look forward to a responsible resumption of the Minor League season in 2021.”

“It’s a privilege to be baseball’s first dual-property partner as well as bring the Minor Leagues back to the game nationwide. We engineered our revolutionary saliva-based PCR testing kits for early detection accuracy and safety. No trade-offs,” said Bill Phillips, Chief Operations Officer for Spectrum Solutions. “After all, if an individual is showing symptoms, they may have already exposed others to that possible infection. Our highly sensitive formulation detects infections from saliva samples measuring as low as 200 copies/ml compared to lateral flow rapid antigen tests that need a minimum of 10,000-20,000 copies/ml.”

The Spectrum Solutions SDNA-1000 Saliva Collection Device was the first saliva-based solution to receive the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for COVID-19 testing. It supplants the need for the painful nasal swab process with a more accurate and pain-free saliva collection process. This easy-to-use option was engineered to eliminate user collection errors and provides a path for at-home sample self-collection that mitigates downstream exposure risks by delivering in-device viral inactivation. Offering the safest & most robust biomaterial for detecting COVID-19, the Spectrum SDNA saliva collection system provides over 10 days of post-collection stability with no degradation in sample efficacy.

###

Contact:  Michael Teevan, Major League Baseball, PublicRelations@MLB.com, @MLB_PR, MLBPressBox.com; Jeff Lantz, Minor League Baseball, JLantz@MiLB.com; Tim Rush, Springboard5 for Spectrum Solutions, tim.rush@springboard5.com.

MLB Announces First Cross-Property Partnership between Minor League Baseball and Major League Baseball

Access this press release on Business Wire

Our Team, Helping your Team, get Back in the Game!

How you collect saliva makes a big diagnostic difference.
Real-world mass testing scenarios require an authorized, proven, and supported system that mitigates any risk of exposure and a company that holds a blackbelt in scalability.
Get your business back in the game.

blank

PROUD PARTNER OF MLB

™/© 2020 MLB

Get to Know Our #PartoftheSolution

Who is Spectrum Solutions?

Headquartered in Salt Lake City, Utah, Spectrum is a life science, medical device manufacturing company focusing its fully-integrated industry expertise on creating forward-looking, and scalable, end-to-end solutions for clinical diagnostic projects and commercialized product plans. A single-source provider of innovative medical device engineering & product manufacturing, molding, chemical formulation, packaging design, customized kitting, & direct-to-user fulfillment, Spectrum’s bio-sample collection devices, patented technologies, and dedicated services deliver measurable process optimization, unprecedented efficiency, and unmatched global scalability.

#partoftheSolution

Leslie Titus Bryant Spectrum Solutions SpokesmanSpectrum Corporate Spokesman
Leslie Titus Bryant
Director of Marketing & Brand
admin@spectrumsolution.com

Tim Rush Public Relations, Springboard 5Media Contact
Tim Rush, Springboard5
801-208-1100
tim.rush@springboard5.com

Get to Know Our #PartoftheSolution

Who is Spectrum Solutions?

Headquartered in Salt Lake City, Utah, Spectrum Solutions is a life science and medical device manufacturing company that focuses its fully-integrated industry expertise on creating forward-looking and scalable end-to-end solutions for clinical diagnostic projects and commercialized product plans. Spectrum is a single-source provider of innovative medical device engineering & product manufacturing, molding, chemical formulation, packaging design, customized kitting, & direct-to-user fulfillment. Its bio-sample collection devices, patented technologies, and dedicated services deliver measurable process optimization, unprecedented efficiency, and unmatched global scalability.

#partoftheSolution

Leslie Titus Bryant Spectrum Solutions SpokesmanSpectrum Corporate Spokesman
Leslie Titus Bryant
Director of Marketing & Brand
admin@spectrumsolution.com

Tim Rush Public Relations, Springboard 5Media Contact
Tim Rush, Springboard5
801-208-1100
tim.rush@springboard5.com

Spectrum
in the News

Spectrum
in the News

Health is a dynamic state of wellbeing. Healthcare providers and researchers have long believed that changes in our saliva record our ongoing state-of-health story. This encrypted source of individual truth, and how to best use it, delivers us all a quicker path to informed decisions and treatments free of adverse reactions.

Interestingly, saliva acts as a wide resource of genomic information useful for identifying and monitoring in real-time a disease as well as its state of progression. Saliva analysis looks at the cellular level, the biologically active compounds, making it a true representative of what is clinically relevant.

Spectrum’s technically-superior saliva collection systems have not only been engineered to lead the saliva collection industry in molecular diagnostics and clinical research applications but deliver the safest, most robust biomaterial for the earliest detection and diagnosis of disease and infection.

  • Saliva provides the earliest path to critical detection and diagnosis
  • Saliva contains the entire library of proteins, hormones, antibodies, and other molecular compounds measured in routine blood tests
  • First EUA authorized saliva collection device for COVID-19 testing & authorized device for direct-to-patient at-home sample self-collection
  • Used in supervised & unsupervised sample collection LDT workflows of symptomatic & asymptomatic users
  • Pain-free, non-invasive, & safe – ideal for those needing frequent & repeat testing
  • In-device live virus inactivation at ambient temps (COVID-19 EUA validated data)
  • Eliminates hooded containment of samples arriving at the testing lab
  • No temperature-controlled storage or transport of collected saliva samples
  • Single device for DNA & viral RNA applications
  • Safest collection approach & most robust biomaterial for detecting COVID-19
  • Delivers 99.998% highest levels of testing accuracy & sensitivity
  • Formulation identifies infections at its earliest stage from as few as 200 copies/ml (lateral flow rapid tests need 10,000-20,000 copies/ml)
  • A single preserved saliva sample provides opportunity for multiple tests
  • Over two weeks of post-collection stability with no degradation in sample efficacy
  • System maintains critical bio-sample consistency
  • Mass-testing scalability & easy device integration using validated and supported processes
  • Mitigates any risk of infection throughout the testing process
  • Pinpoint life-cycle stage of active viral infection
  • Eliminates UN3373 shipping designation with clearance from USPS, FedEx, & UPS
  • Delivers the highest levels of testing accuracy using qualified extraction chemistries
Questions? Let’s Connect
Contact Us

Are you a lab?
Let’s connect.

#partofthesolution

How can we help?
Let’s Chat

Looking for a customized testing or life science product solution? Benefit from our experience, industry understanding, and process support.